Importantly, our study raises questions about the clinical significance of low-level cryptococcal antigenemia among patients receiving ART and supports interim WHO guidelines recommending CRAG screening only for ART-naïve patients with low CD4 counts as well as CSF testing in symptomatic patients presenting with meningitis. This evidence concerns the gene CD4 and infectious meningitis.